Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
RESEARCH LETTER
Association between single-nucleotide polymorphisms of ADAMTS13 and severe COVID-19: a case-control study in Chinese Han adults
1
Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China
2
Department of Respiratory and Critical Care Medicine, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
These authors had equal contribution to this work
Submission date: 2024-10-04
Final revision date: 2024-12-24
Acceptance date: 2024-12-25
Online publication date: 2024-12-31
Corresponding author
Jianqing He
Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University,, No. 37, Guo Xue Alley, 610041, Chengdu, China
Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University,, No. 37, Guo Xue Alley, 610041, Chengdu, China
TOPICS
REFERENCES (19)
1.
World Health Organization. COVID-19 epidemiological update-6 November 2024. https://www.who.int/publicatio....
2.
Inchingolo AD, Inchingolo AM, Bordea IR, et al. SARS-CoV-2 disease through viral genomic and receptor implications: an overview of diagnostic and immunology breakthroughs. Microorganisms 2021; 9: 793.
3.
Tzotzos SJ, Fischer B, Fischer H, et al. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey. Crit Care 2020; 24: 516.
4.
Maiese A, Manetti AC, La Russa R, et al. Autopsy findings in COVID-19-related deaths: a literature review. Forensic Sci Med Pathol 2021; 17: 279-96.
5.
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708-20.
6.
Feng Y, Li X, Xiao J, et al. ADAMTS13: more than a regulator of thrombosis. Int J Hematol 2016; 104: 534-9.
7.
Severe Covid-19 GWAS Group; Ellinghaus D, Degenhardt F, Bujanda L, et al. Genomewide association study of severe covid-19 with respiratory failure. N Engl J Med 2020; 383: 1522-34.
8.
Sinkovits G, Reti M, Muller V, et al. Associations between the von Willebrand factor-ADAMTS13 axis, complement activation, and COVID-19 severity and mortality. Thromb Haemost 2022; 122: 240-56.
9.
Mandell LA, Wunderink RG, Anzueto A, et al. Infectious diseases society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 Suppl 2: S27-72.
10.
Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005; 15: 97-8.
11.
Cappadona C, Paraboschi EM, Ziliotto N, et al. MEDTEC students against coronavirus: investigating the role of hemostatic genes in the predisposition to COVID-19 severity. J Pers Med 2021; 11: 1166.
12.
de Vries PS, Boender J, Sonneveld MA, et al. Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activity. Blood 2015; 125: 3949-55.
13.
Pagliari MT, Cairo A, Boscarino M, et al. Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis. PLoS One 2021; 16: e0258675.
14.
Weiss KM, Clark AG. Linkage disequilibrium and the mapping of complex human traits. Trends Genet 2002; 18: 19-24.
15.
Sayyadi M, Hassani S, Shams M, et al. Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement. Ann Hematol 2023; 102: 1307-22.
16.
Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 2020; 18: 1738-42.
17.
Zguro K, Baldassarri M, Fava F, et al. Carriers of ADAMTS13 rare variants are at high risk of life-threatening COVID-19. Viruses 2022; 14: 1185.
18.
Leentjens J, van Haaps TF, Wessels PF, et al. COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year. Lancet Haematol 2021; 8: e524-33.
19.
Oktaviono YH, Mulia EPB, Luke K, et al. Right ventricular dysfunction and pulmonary hypertension in COVID-19: a meta-analysis of prevalence and its association with clinical outcome. Arch Med Sci 2022; 18: 1169-80.
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
